Hi, I’m Jessica Skarzynski for CURE Magazine®, your guide to every stage of the cancer experience.
Here’s a look at what’s inside our 2019 Genitourinary Cancers special issue:
Active surveillance has become the gold standard for low-risk prostate cancer, but challenges remain. What new diagnostic tools can be used to make it more precise? In this issue’s cover story, we delve deeper into how experts are Polishing the Gold Standard.
Next, when it comes to treating kidney cancer — more may be better. A One-Two Punch approach, with immunotherapy and targeted treatment, offers a better alternative to single agents.
To read these stories and more, visit our Genitourinary Cancers Special Issue online.
Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit curetoday.com/email-profile for more information.
And, as always, thanks for reading.
